Figure 2: Improvement in Psoriasis Area and Severity Index score in all three groups at 0, 4, 8 and 12 weeks. Group A: Standard treatment group – methotrexate, Group B: Active treatment group – pioglitazone, Group C: Combination therapy – methotrexate + pioglitazone